Stay updated on Switch Maintenance in Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Switch Maintenance in Pancreatic Clinical Trial page.

Latest updates to the Switch Maintenance in Pancreatic Clinical Trial page
- Check2 days agoChange DetectedNew entries show 'Efficacy concerns' and 'Suspended' with dates 2026-01-14 and 2026-01-15, signaling a change in trial status. The Recruiting status and the principal investigator's contact information (email and phone) have been removed.SummaryDifference1.0%

- Check9 days agoChange DetectedMinor site revision updated from v3.3.3 to v3.3.4; this change does not affect study details, eligibility criteria, or page navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe study record was revised to Phase Ib Open-Label, Multicenter, non-randomized design evaluating switch maintenance using AB154, AB122, and Sotigalimab in metastatic pancreatic cancer, with Massachusetts as a participating location. Eligibility criteria were updated to exclude germline BRCA mutations, and endpoints now include PFS2.SummaryDifference1%

- Check59 days agoChange DetectedPage revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check66 days agoChange DetectedNotice about lapse in government funding and NIH/Center for Operations status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedThe new screenshot shows minor layout adjustments and an updated last updated date, while core study details, eligibility criteria, endpoints, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Switch Maintenance in Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switch Maintenance in Pancreatic Clinical Trial page.